Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer
Author:
Affiliation:
1. Department of Pharmaceutics
2. State Key Laboratory of Natural Medicines
3. China Pharmaceutical University
4. Nanjing 210009
5. China
Abstract
Tumor metastasis has become a major obstacle for the clinical treatment of malignant breast cancer.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Jiangsu Province
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering
Link
http://pubs.rsc.org/en/content/articlepdf/2018/BM/C8BM00486B
Reference65 articles.
1. Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years
2. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
3. Illuminating the metastatic process
4. Development of individualized anti-metastasis strategies by engineering nanomedicines
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biomedical applications of engineered heparin-based materials;Bioactive Materials;2024-01
2. Specifics of Pharmacokinetics and Biodistribution of 5-Fluorouracil Polymeric Complex;Molecules;2023-12-15
3. Advances in anti-tumor research based on bionic micro-nano technology;Journal of Drug Delivery Science and Technology;2023-09
4. Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues;Pharmaceuticals;2023-03-13
5. Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy;Small;2023-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3